Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus® 5 Rechargeable Battery System for adults and children with severe-to-profound hearing loss.
“Rechargeable batteries offer patients a cost-effective and environmentally-friendly alternative to traditional disposable battery technology,” says Teresa Adkins, Vice President of Marketing for Cochlear Americas.
Cochlear has offered rechargeable batteries with previous generation hearing systems, but with Nucleus 5, our engineers have achieved an exciting industry breakthrough - when using rechargeable batteries, the Nucleus 5 Sound Processor is the world’s ONLY submergible sound processor.
According to Chris Smith, President of Cochlear Americas, “This represents a fundamental leap forward for those who benefit from our cochlear implant technology. No other cochlear implant system has ever come close to providing patients with this level of confidence around water. With other cochlear implant systems, patients are forced to weigh the risk of accidentally dropping their sound processor in water and destroying it versus the benefit of hearing in and around water. With Nucleus 5, when using our new rechargeable battery option, there are no risks to weigh. During the summer months this is especially noteworthy, since water-based activities are such an important part of many of our patients’ lives.”